The FCC’s independent commission model is stuck in a bygone era and should be scrapped, argues University of Florida economist Dr. Mark Jamison.
Explore Iran's surprising defence capabilities and inherent weaknesses amidst the escalating Middle East conflict. Read more at straitstimes.com. Read more at straitstimes.com.
Merck's blockbuster immunotherapy Keytruda, which generates nearly half of its total revenue, is scheduled to lose U.S. patent protection in 2028, opening the door to lower-cost generic competition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results